CONMED traded at $41.52 this Friday February 6th, increasing $0.86 or 2.12 percent since the previous trading session. Looking back, over the last four weeks, CONMED gained 4.33 percent. Over the last 12 months, its price fell by 37.50 percent. Looking ahead, we forecast CONMED to be priced at 37.21 by the end of this quarter and at 33.87 in one year, according to Trading Economics global macro models projections and analysts expectations.
CONMED Corporation is a medical technology company that is engaged in the development, manufacturing, and sale on a global basis of surgical devices and related equipment. The Company's products consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including dissociated two horizontal deviation and three horizontal deviation vision technologies. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Its products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.